View in EDS HTML Full Text PDF Full Text

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.

Saved in:
Bibliographic Details
Title: SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Authors: Gutiérrez-Chamorro, Lucía1 (AUTHOR), Felip, Eudald1,2 (AUTHOR), Castellà, Eva3 (AUTHOR), Quiroga, Vanessa2 (AUTHOR), Ezeonwumelu, Ifeanyi Jude1 (AUTHOR), Angelats, Laura2 (AUTHOR), Esteve, Anna2 (AUTHOR), Perez-Roca, Laia4 (AUTHOR), Martínez-Cardús, Anna2 (AUTHOR), Fernandez, Pedro Luis3 (AUTHOR), Ferrando-Díez, Angelica2 (AUTHOR), Pous, Anna2 (AUTHOR), Bergamino, Milana2 (AUTHOR), Cirauqui, Beatriz2 (AUTHOR), Romeo, Marga2 (AUTHOR), Teruel, Iris2 (AUTHOR), Mesia, Ricard2 (AUTHOR), Clotet, Bonaventura1 (AUTHOR), Riveira-Muñoz, Eva1 (AUTHOR), Margelí, Mireia2 (AUTHOR) mmargeli@iconcologia.net
Source: Cellular Oncology (2211-3428). Feb2024, Vol. 47 Issue 1, p189-208. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:22113428
DOI:10.1007/s13402-023-00862-1